Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-center Trial Evaluating the Safety and Efficacy of MUC-1/WT-1 Peptide or Tumor Lysate-pulsed Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer

NCT03114631 is registered in ClinicalTrials.gov with The Republican Research and Practical Center for Epidemiology and Microbiology as lead sponsor.

NCT NCT03114631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03114631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-center Trial Evaluating the Safety and Efficacy of MUC-1/WT-1 Peptide or Tumor Lysate-pulsed Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer
Lead sponsor
The Republican Research and Practical Center for Epidemiology and Microbiology
Phase
Phase 1/2
Overall status
Completed
Start date
January 9, 2017
Completion date
May 23, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dendritic cells, pancreatic neoplasms